Medtronic is a global leader in medical technology, services, and solutions. We collaborate with others to take on healthcare's greatest challenges. See how.
#1 insulin pump in overall satisfaction1-3 Get started Find resources for your diabetes journey Whether you're newly diagnosed, considering a technology switch, or a caregiver for someone living with diabetes, we have resources designed to help you on your journey. Automated insulin delivery Aut...
MiniMed对胰岛素注射泵Insulin Pump（注册证号：国械注进20173141951）主动召回。召回级别为一级。涉及产品的型号、规格及批次等详细信息见《医疗器械召回事件报告表》。附件：医疗器械召回事件报告表 2021年12月10日 美敦力泌力美公司Medtronic MiniMed对胰岛素注射泵Insulin Pump主动召回.pdf ...
The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide Test Strips. The syste...
美敦力(上海)管理有限公司报告,由于涉及特定型号、特定批次产品,MMT-503EU遥控器存在潜在安全漏洞的问题。生产商美敦力泌力美公司Medtronic MiniMed对胰岛素注射泵Insulin Pump(注册证号:国械注进20173141951)主动召回。召回级别为一级。涉及产品的型号、规格及批次等详细信息见《医疗器械召回事件报告表》。
1 in automated insulin delivery as Q1 results highlight Diabetes growth August 20, 2024 By Sean Whooley Medtronic (NYSE:MDT) reported more growth in its Diabetes unit as the company’s recent moves signal its intent in the competitive insulin pump market. The company’s first-quarter (...
INSULIN PUMP HACKING UNLIKELY, SAYS MEDTRONIC.The article reports that Medtronic has asserted that the risk of insulin pump hacking is extremely low, in response to diabetic patient Jay Radcliffe's claim that the company's insulin pumps can be controlled remotely....
“Medtronic and Chengdu share a commitment to transform diabetes care through advanced therapies that can provide greater freedom and better health to over one hundred million people living with diabetes in China,” intensive insulin management president Alejandro Galindo said in prepared remarks. “By ...
Medtronic said it has entered into definitive agreements to acquire EOFlow, a Korean company specializing in wearable insulin pumps, and announced its intention to delist the company from the tech-heavy Kosdaq market.Under the definitive agreements, Medt
"Patients with diabetes using these models should switch their insulin pump to models that are better equipped to protect against these potential risks," the U.S. Food and Drug Administration said in astatement. The pumps work by using a wireless radio frequency to communicate with other devices...